Shu Dong
Impact in
- Developmental Biology top 2%
- Animal Vocal Communication and Behavior
- Hepatology top 5%
Papers in
- Oncology 21
- Pancreatic and Hepatic Oncology Research 9
- Cancer Immunotherapy and Biomarkers 5
- Co-authors
- David F. Clayton (4 shared papers)Shi-Bing Su (9 shared papers)Ping Liu (6 shared papers)Mingyu Sun (4 shared papers)Hongyan Cao (4 shared papers)Yanqin Bian (4 shared papers)Qiwen Chen (3 shared papers)Fei Huang (1 shared paper)
- Journals
- Journal of Clinical Oncology (4 papers)Evidence-based Complementary and Alternative Medicine (3 papers)World Journal of Surgical Oncology (2 papers)Chinese Medicine (2 papers)Bioscience Reports (2 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Shu Dong
53 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 111
- Developmental Biology 137
- Hepatology 118
- Pharmacology 121
- Cancer Research 208
- Ecology, Evolution, Behavior and Systematics 153
Countries citing papers authored by Shu Dong
This map shows the geographic impact of Shu Dong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shu Dong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shu Dong more than expected).
Fields of papers citing papers by Shu Dong
This network shows the impact of papers produced by Shu Dong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shu Dong. The network helps show where Shu Dong may publish in the future.
Co-authors
The 25 scholars most cited alongside Shu Dong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 60 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 101 | |
| 2 | 2012 | 88 | |
| 3 | 2019 | 76 | |
| 4 | 2008 | 68 | |
| 5 | 2009 | 63 | |
| 6 | 2020 | 58 | |
| 7 | 2017 | 56 | |
| 8 | 2017 | 50 | |
| 9 | 1983 | 48 | |
| 10 | 2015 | 42 | |
| 11 | 2017 | 41 | |
| 12 | 2009 | 40 | |
| 13 | 2008 | 30 | |
| 14 | 2017 | 30 | |
| 15 | 2017 | 28 | |
| 16 | 2015 | 27 | |
| 17 | 2019 | 25 | |
| 18 | 2016 | 22 | |
| 19 | 2014 | 20 | |
| 20 | 2022 | 18 |
About Shu Dong
Shu Dong is a scholar working on Oncology, Molecular Biology, Epidemiology, Pulmonary and Respiratory Medicine and Hepatology, having authored 60 papers that have together received 1.2k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (11 papers), Pancreatic and Hepatic Oncology Research (9 papers), Liver physiology and pathology (6 papers), Hepatitis B Virus Studies (5 papers), Cancer Immunotherapy and Biomarkers (5 papers), Cancer-related molecular mechanisms research (5 papers), Lung Cancer Treatments and Mutations (5 papers) and Marine animal studies overview (4 papers). The work is most often cited by research in Developmental Biology (137 citations), Hepatology (118 citations), Pharmacology (121 citations), Cancer Research (208 citations) and Ecology, Evolution, Behavior and Systematics (153 citations). Shu Dong has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include David F. Clayton, Shi-Bing Su, Ping Liu, Mingyu Sun, Hongyan Cao, Yanqin Bian, Qiwen Chen, Fei Huang, Hao Zhang and Kirstin Replogle. Their work appears in journals such as Journal of Clinical Oncology, Evidence-based Complementary and Alternative Medicine, World Journal of Surgical Oncology, Chinese Medicine and Bioscience Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.